| [1] |
Hu YW,Zhang P,Yang JY,et al.Nur77 decreases atherosclerosis progression in ApoE(-/-) mice fed a high-fat/high-cholesterol diet[J].PLoS ONE,2014,9(1):e87313.
|
| [2] |
Yang P,Wei X,Zhang J,et al.Antithrombotic effects of Nur77 and Nor1 are mediated through upregulating thrombomodulin expression in endothelial cells[J].Arterioscler Thromb Vasc Biol,2016,36(2):361-369.
|
| [3] |
Xie X, Song X, Yuan S, et al. Histone acetylation regulates orphan nuclear receptor NR4A1 expression in hypercholesterolemia[J].Clin Sci,2015,129(12):1151-1161.
|
| [4] |
Lu Z,Zhang X,Li Y,et al.TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes[J].Immumobiology,2015,220(11):1246-1254.
|
| [5] |
Ren M,Li R,Luo M,et al.Endothelial cells but not platelets are the major source of Toll-like receptor 4 in the arterial thrombosis and tissue factor expression in mice[J].Am J Physiol Regul Integr Comp Physiol,2014,307(7):R901-R907.
|
| [6] |
Opal SM,Pierre-Francois L,Bruno F,et al.Effect of eritoran,an antagonist of MD2-TLR4,on mortality in patients with severe sepsis:the ACCESS randomized trial[J].JAMA,2013,309(11):1154-1162.
|
| [7] |
Tsou TC,Liou SH,Yeh SC,et al.Crucial role of Toll-like receptors in the zinc/nickel-induced inflammatory response in vascular endothelial cells[J].Toxicol Appl Pharmacol,2013,273(3):492-499.
|
| [8] |
Balakumar P,Kathuria S.Submaximal PPARgamma activation and endothelial dysfunction:new perspectives for the management of cardiovascular disorders[J].Br J Pharmacol,2012,166(7):1981-1992.
|
| [9] |
Pasterk L,Lemesch S,Leber B,et al.Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression [J].Sci Rep,2016,6:22104.
|
| [10] |
Chen D,Xia M,Hayford C,et al.Expression of human tissue factor pathway inhibitor on vascular smooth muscle cells inhibits secretion of macrophage migration inhibitory factor and attenuates atherosclerosis in ApoE-/- mice[J].Circulation,2015,131(15):1350-1360.
|
| [11] |
Zhai KF, Tang YM, Zhang YY, et al. NMMHC IIA inhibition impedes tissue factor expression and venous thrombosis via Akt/GSK3β-NF-κB signalling pathways in the endothelium[J].Thromb Haemost,2015,114(1):173-185.
|
| [12] |
Shi W,Mei H,Deng J,et al.The delivery of thrombi-specific nanoparticles incorporating oligonucleotides into injured cerebrovascular endothelium[J].Biomaterials,2013,34(16):4128-4136.
|
| [13] |
Wan W,Lionakis MS,Liu Q,et al.Genetic deletion of chemokine receptor Ccr7 exacerbates atherogenesis in ApoE-deficient mice[J].Cardiovasc Res,2013,97(3):580-588.
|
| [14] |
Wan W,Liu Q,Lionakis MS,et al.Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice[J].Cardiovasc Res,2015,6(3):478-487.
|
| [15] |
Majmudar MD,Keliher EJ,Heidt T,et al.Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice[J].Circulation,2013,127(20):2038-2046.
|
| [16] |
de Zeeuw D, Bekker P, Henkel E, et al. The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy:a randomised trial[J].Lancet Diabetes Endocrinol,2015,3(9):687-696.
|
| [17] |
Gilbert J,Lekstrom-Himes J,Donaldson D,et al.Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region[J].Am J Cardiol,2011,107(6):906-911.
|
| [18] |
Pelham CJ,Keen HL,Lentz SR,et al.Dominant negative PPAR gamma promotes atherosclerosis,vascular dysfunction,and hypertension through distinct effects in endothelium and vascular muscle[J].Am J Physiol Regul Integr Comp Physiol,2013,304(9):R690-701.
|
| [19] |
Amato AA,Rajagopalan S,Lin JZ,et al.GQ-16,a novel peroxisome proliferator-activated receptor γ(PPARγ)ligand,promotes insulin sensitization without weight gain[J].J Biol Chem,2012,287(33):28169-28179.
|
| [20] |
Silva JC, César FA, de Oliveira EM, et al. New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr(-/-) mice[J].Pharmacol Res,2016,104:49-60.
|
| [21] |
Shih CY,Chou TC.The antiplatelet activity of magnolol is mediated by PPAR-β/γ[J].Biochem Pharmacol,2012,84(6):793-803.
|
| [22] |
Van Gils JM,Derby MC,Fernandes LR,et al.The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques[J].Nat Immunol,2012,13(2):136-143.
|
| [23] |
Ramkhelawon B,Yang Y,Van Gils JM,et al.Hypoxia induces netrin-1 and Unc5b in atherosclerotic plaques:mechanism for macrophage retention and survival[J].Arterioscler Thromb Vasc Biol,2013,33(6):1180-1188.
|
| [24] |
Zhan B,Kong C,Guo K,et al.PKCα is involved in the progression of kidney carcinoma through regulating netrin-1/UNC5B signaling pathway[J].Tumour Biol,2013,34(3):1759-1766.
|
| [25] |
Gao X,Metzger U,Panza P,et al.A floor-plate extracellular protein-protein interaction screen identifies Draxin as a secreted netrin-1 antagonist[J].Cell Rep,2015,12(4):694-708.
|
| [26] |
Ungerer M,Li Z,Baumgartner C,et al.The GPVI-Fc fusion protein Revacept reduces thrombus formation and improves vascular dysfunction in atherosclerosis without any impact on bleeding times[J].PLoS ONE,2013,8(8):e71193-e71193.
|
| [27] |
Ungerer M,Rosport K,Bültmann A,et al.Novel antiplatelet drug revacept(dimeric glycoprotein VI-Fc)specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans[J].Circulation,2011,123(17):1891-1899.
|
| [28] |
Jiang P,Loyau S,Tchitchinadze M,et al.Inhibition of glycoprotein VI clustering by collagen as a mechanism of inhibiting collagen-induced platelet responses:the example of losartan[J].PLoS ONE,2015,10(6):e0128744.
|
| [29] |
Lu WJ,Wu MP,Lin KH,et al.Hinokitiol is a novel glycoprotein VI antagonist on human platelets[J].Platelets,2014,25(8):595-602.
|
| [30] |
Chen W,Carvalho LP,Chan MY,et al.Fasxiator,a novel factor XIa inhibitor from snake venom,and its site-specific mutagenesis to improve potency and selectivity[J].J Thromb Haemost,2015,13(2):248-261.
|
| [31] |
Al-Horani RA,Ponnusamy P,Mehta AY,et al.Sulfated pentagalloylglucoside is a potent,allosteric,and selective inhibitor of factor XIa[J].J Med Chem,2013,56(3):867-878.
|
| [32] |
van Montfoort ML,Kuijpers MJ,Knaup VL,et al.Factor XI regulates pathological thrombus formation on acutely ruptured atherosclerotic plaques[J].Arterioscler Thromb Vasc Biol,2014,34(8):1668-1673.
|
| [33] |
Xu Y,Cai TQ,Castriota G,et al.Factor XIIa inhibition by infestin-4:in vitro mode of action and in vivo antithrombotic benefit[J].Thromb Haemost,2014,111(4):694-704.
|
| [34] |
Krupka J, May F, Weimer T, et al. The coagulation factor XIIa inhibitor rHA-infestin-4 improves outcome after cerebral ischemia/reperfusion injury in rats[J].PLoS ONE,2016,11(1):e0146783.
|
| [35] |
Baeriswyl V,Calzavarini S,Gerschheimer C,et al.Development of a selective peptide macrocycle inhibitor of coagulation factor XII toward the generation of a safe antithrombotic therapy[J].J Med Chem,2013,56(9):3742-3746.
|
| [36] |
Larsson M,Rayzman V,Nolte MW,et al.A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk[J].Sci Transl Med,2014,6(222):222ra17.
|
| [37] |
Yau JW,Stafford AR,Liao P,et al.Corn trypsin inhibitor coating attenuates the prothrombotic properties of catheters in vitro and in vivo[J].Acta Biomater,2012,8(11):4092-4100.
|
| [38] |
Su EJ,Geyer M,Wahl M,et al.The thrombomodulin analog solulin promotes reperfusion and reduces infarct volume in a thrombotic stroke model[J].J Thromb Haemost,2011,9(6):1174-1182.
|
| [39] |
Vicente CP, Weiler H, Di Cera E, et al. Thrombomodulin is required for the antithrombotic activity of thrombin mutant W215A/E217A in a mouse model of arterial thrombosis[J].Thromb Res,2012,130(4):646-648.
|
| [40] |
Vincent JL,Ramesh MK,Ernest D,et al.A randomized,double-blind,placebo-controlled,Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin,ART-123,in patients with sepsis and suspected disseminated intravascular coagulation[J].Crit Care Med,2013,41(9):2069-2079.
|
| [41] |
Andersson HM,Siegerink B,Luken BM,et al.High VWF,low ADAMTS13,and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women[J].Blood,2012,119(6):1555-1560.
|
| [42] |
Pickens B, Mao Y, Li D, et al. Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models[J].Blood,2015,125(21):3326-3334.
|
| [43] |
Kopi'c A,Benamara K,Piskernik C,et al.Preclinical assessment of a new recombinant ADAMTS-13 drug product(BAX930)for the treatment of thrombotic thrombocytopenic purpura[J].J Thromb Haemost,2016,14(7):1410-1419.
|
| [44] |
Holy EW, Jakob P, Eickner T, et al. PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation,but not re-endothelialization:potential implications for drug-eluting stent design[J].Eur Heart J,2014,35(12):808-820.
|
| [45] |
Nylander S,Kull B,Björkman JA,et al.Human target validation of phosphoinositide 3-kinase(PI3K)β:effects on platelets and insulin sensitivity,using AZD6482 a novel PI3Kβ inhibitor[J].J Thromb Haemost,2012,10(10):2127-2136.
|
| [46] |
Yi W,Li Q,Shen J,et al.Modulation of platelet activation and thrombus formation using a pan-PI3K inhibitor S14161[J].PLoS ONE,2014,9(8):e102394.
|
| [47] |
Zheng Z,Pinson JA,Mountford SJ,et al.Discovery and antiplatelet activity of a selective PI3Kβ inhibitor(MIPS-9922)[J].Eur J Med Chem,2016,122:339-351.
|
| [48] |
Kwon HW,Shin JH,Cho HJ,et al.Total saponin from Korean Red Ginseng inhibits binding of adhesive proteins to glycoprotein IIb/IIIa via phosphorylation of VASP(Ser(157))and dephosphorylation of PI3K and Akt[J].J Ginseng Res,2016,40(1):76-85.
|
| [49] |
Hahm E,Li J,Kim K,et al.Extracellular protein disulfide isomerase regulates ligand-binding activity of αMβ2 integrin and neutrophil recruitment during vascular inflammation[J].Blood,2013,121(19):3789-3800.
|
| [50] |
Wang L,Wu Y,Zhou J,et al.Platelet-derived ERp57 mediates platelet incorporation into a growing thrombus by regulation of the αIIbβ3 integrin[J].Blood,2013,122(22):3642-3650.
|
| [51] |
Cui G,Shan L,Guo L,et al.Novel anti-thrombotic agent for modulation of protein disulfide isomerase family member ERp57 f or prophylactic therapy[J].Sci Rep,2015,5:10353.
|
下载:
